Loading...
Loading...
According to Auriga, Allscripts-Misys
MDRX price target is raised to $25.
Auriga said that it is reiterating its BUY rating on Allscripts (
MDRX) following an in-line quarter and guide. “Our new target, up from $23, is based on our newly introduced FY13 estimates.”
Allscripts-Misys closed yesterday at $21.47.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in